HuagongsheHuagongshe Chemistry Print Report · For research reference only
Cyclopropanecarboxylic acid → N-(2-(4-(Cyclopropanecarboxamido)phenyl)-2H-indazol-5-yl)-4-(4-hydroxypiperidin-1-yl)benzamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Cyclopropanecarboxylic acid | HCID 15655 | — |
| Reactant | 4-(4-Hydroxy-1-piperidinyl)benzoic acid | HCID 18617591 | — |
| Reactant | 5-Amino-2-(4-aminophenyl)indazole | HCID 67112580 | — |
| Product | N-(2-(4-(Cyclopropanecarboxamido)phenyl)-2H-indazol-5-yl)-4-(4-hydroxypiperidin-1-yl)benzamide | HCID 67113641 | — |
Reaction Steps
Compound 681 was prepared according to the procedure similar to that described in Scheme IV from 4-(4-hydroxypiperidin-1-yl)benzoic acid, cyclopropanecarboxylic acid, and 2-(4-aminophenyl)-5-amino-2H-indazole. [M+H]+ calcd for C29H29N5O3: 496.23; found 496.05.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09144557B2 |
| Source dataset | uspto-grants-2015_09 |
| ORD ID | ord-4bda7cc2f49b4df6b285cc3106cdac20 |
| Source note | uspto-grants-2015_09 |